Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.

Eggermont AM, Schraffordt Koops H, Liénard D, Kroon BB, van Geel AN, Hoekstra HJ, Lejeune FJ.

J Clin Oncol. 1996 Oct;14(10):2653-65.

PMID:
8874324
2.

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.

Eggermont AM, Schraffordt Koops H, Klausner JM, Kroon BB, Schlag PM, Liénard D, van Geel AN, Hoekstra HJ, Meller I, Nieweg OE, Kettelhack C, Ben-Ari G, Pector JC, Lejeune FJ.

Ann Surg. 1996 Dec;224(6):756-64; discussion 764-5.

3.

Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.

Lejeune FJ, Pujol N, Liénard D, Mosimann F, Raffoul W, Genton A, Guillou L, Landry M, Chassot PG, Chiolero R, Bischof-Delaloye A, Leyvraz S, Mirimanoff RO, Bejkos D, Leyvraz PF.

Eur J Surg Oncol. 2000 Nov;26(7):669-78.

PMID:
11078614
4.

Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.

Noorda EM, Vrouenraets BC, Nieweg OE, van Coevorden F, van Slooten GW, Kroon BB.

Cancer. 2003 Oct 1;98(7):1483-90.

5.

Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas.

Deroose JP, Eggermont AM, van Geel AN, Burger JW, den Bakker MA, de Wilt JH, Verhoef C.

J Clin Oncol. 2011 Oct 20;29(30):4036-44. doi: 10.1200/JCO.2011.35.6618. Epub 2011 Sep 19.

PMID:
21931039
6.

The palliative value of tumor necrosis factor alpha-based isolated limb perfusion in patients with metastatic sarcoma and melanoma.

Grunhagen DJ, de Wilt JH, Graveland WJ, van Geel AN, Eggermont AM.

Cancer. 2006 Jan 1;106(1):156-62.

7.

Long-term outcome of isolated limb perfusion in advanced soft tissue sarcoma of the extremity.

Olofsson R, Bergh P, Berlin O, Engström K, Gunterberg B, Hansson M, Lindnér P, Mattsson J.

Ann Surg Oncol. 2012 Jun;19(6):1800-7. doi: 10.1245/s10434-011-2196-z. Epub 2012 Jan 5.

PMID:
22219068
8.

Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients.

Cherix S, Speiser M, Matter M, Raffoul W, Liénard D, Theumann N, Mouhsine E, Mirimanoff RO, Leyvraz S, Lejeune FJ, Leyvraz PF.

J Surg Oncol. 2008 Sep 1;98(3):148-55. doi: 10.1002/jso.21081.

PMID:
18668638
10.

High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation.

Gutman M, Inbar M, Lev-Shlush D, Abu-Abid S, Mozes M, Chaitchik S, Meller I, Klausner JM.

Cancer. 1997 Mar 15;79(6):1129-37.

PMID:
9070490
11.

Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection.

Jakob J, Tunn PU, Hayes AJ, Pilz LR, Nowak K, Hohenberger P.

J Surg Oncol. 2014 Jun;109(8):786-90. doi: 10.1002/jso.23591. Epub 2014 Mar 12.

PMID:
24619722
12.

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity.

Bickels J, Manusama ER, Gutman M, Eggermont AM, Kollender Y, Abu-Abid S, Van Geel AN, Lev-Shlush D, Klausner JM, Meller I.

Eur J Surg Oncol. 1999 Oct;25(5):509-14.

PMID:
10527599
14.

Radiotherapy for soft tissue sarcomas after isolated limb perfusion and surgical resection: essential for local control in all patients?

Deroose JP, Burger JW, van Geel AN, den Bakker MA, de Jong JS, Eggermont AM, Verhoef C.

Ann Surg Oncol. 2011 Feb;18(2):321-7. doi: 10.1245/s10434-010-1400-x. Epub 2010 Nov 4.

15.

Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma.

Olieman AF, Pras E, van Ginkel RJ, Molenaar WM, Schraffordt Koops H, Hoekstra HJ.

Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):807-14.

PMID:
9531364
16.
17.

[Limb perfusion in soft tissue sarcomas: twenty years of experience].

Hoven-Gondrie ML, Bastiaannet E, van Ginkel RJ, Pras EB, Suurmeijer A, Hoekstra HJ.

Ned Tijdschr Geneeskd. 2013;157(30):A6148. Dutch.

PMID:
23890169
18.
20.

Supplemental Content

Support Center